AI brief of an SEC Form 8-K · Bruker (BRKR)

Bruker Q1 revenue rises 11% to $801.4 million, but company lowers 2025 EPS and organic growth outlook

Mixed Impact 4 of 5 guidance Written later

Bruker reported first quarter 2025 revenue of $801.4 million, up 11.0% year over year, but non-GAAP diluted EPS fell 11.3% to $0.47 and GAAP diluted EPS was $0.11, down from $0.35. The company lowered its full-year 2025 organic revenue growth and non-GAAP EPS guidance, citing academic market and tariff dynamics, which points to a weaker profit outlook for shareholders.

Key points

  • Q1 2025 revenue $801.4 million, up 11.0%; organic revenue growth 2.9%
  • Q1 non-GAAP diluted EPS $0.47, down 11.3% from $0.53; GAAP diluted EPS $0.11 vs. $0.35
  • FY 2025 non-GAAP EPS guidance $2.40 to $2.48, implying 0% to 3% growth; organic revenue growth 0% to 2%
  • Q1 non-GAAP operating margin 12.7% vs. 14.0% a year earlier

The filing

CompanyBruker (BRKR)
Form8-K, current report
Filed with the SECMay 7, 2025, 7:00 AM ET
Accession number0000950170-25-064973

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:17 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 07, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.